Fresenius Medical Care AG & Co. FMS reported fourth-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which surpassed the Zacks Consensus Estimate by 23.9%. The bottom line surged 59% year ...
Zacks Investment Research on MSN
Reasons to retain Fresenius Medical stock in your portfolio for now
Fresenius Medical Care AG & Co. FMS is well-positioned for growth, backed by strong profitability improvements from its ...
Fresenius Medical Care AG & Co. FMS reported second-quarter 2025 adjusted earnings per share (EPS) of 52 cents, which surpassed the Zacks Consensus Estimate by 4%. The bottom line improved 36.8% year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results